Genistein, in the glioma cell line U87MG at a dose of 10 μM, increases the arrest of the G2/M cell cycle and cellular apoptosis by downregulating the protein levels of MT1‐MMP and uPAR, as well as MMP‐2 and MMP‐9.173. This evidence concerns the gene MMP9 and central nervous system cancer.